Total item
Cart Subtotal
$0.00 c-Kit
| Catalog No. | Inhibitor Name | c-Kit | Other |
|---|---|---|---|
| A10290 | Dasatinib | *** | Abl,Src |
| A10468 | Imatinib Mesylate | ** | PDGFR,v-Abl |
| A10996 | Cabozantinib | *** | VEGFR2/KDR,c-Met,VEGFR3/FLT4 |
| A10103 | Axitinib | **** | VEGFR1/FLT1,VEGFR2/Flk1,VEGFR2/KDR |
| A10699 | Pazopanib HCl | * | VEGFR1,VEGFR2,VEGFR3 |
| A11411 | Dovitinib | **** | FLT3,FGFR1,VEGFR3/FLT4 |
| A10967 | Vatalanib 2HCl | * | VEGFR2/KDR,VEGFR1/FLT1,VEGFR2/Flk1 |
| A10558 | Masitinib | * | Lyn B,PDGFRα,PDGFRβ |
| A10101 | Tivozanib | ** | VEGFR2,VEGFR3,EphB2 |
| A10610 | Amuvatinib | *** | PDGFRα (V561D),FLT3 (D835Y) |
| A10608 | Motesanib Diphosphate | *** | VEGFR1,VEGFR2,VEGFR2/Flk1 |
| A10679 | OSI-930 | ** | FLT1,KDR,CSF-1R |
| A10502 | Ki8751 | ** | VEGFR2,PDGFRα,FGFR2 |
| A10903 | Telatinib | **** | VEGFR3,VEGFR2,PDGFRα |
| A11518 | Pazopanib | * | VEGFR1,VEGFR2,VEGFR3 |
| A10198 | Dovitinib Dilactic Acid | **** | FLT3,FGFR1,VEGFR3/FLT4 |
| A16320 | Dasatinib Monohydrate | *** | Abl ,Src |
| A14156 | AZD2932 | *** | PDGFRβ,Flt3,VEGFR-2 |
| A10880 | Sunitinib Malate | FLT3,PDGFRβ,VEGFR2 | |
| A15062 | DCC-2618 | *** | PDGFRα, PDGFRβ |
| A15519 | PLX647 | *** | Fms |
| A15520 | Pexidartinib (PLX3397) | *** | CSF-1R, Flt-3 |
Notes:
1.Hover mouse over "" to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of "" is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
40 Item(s)
per page
-
Ki 20227
Catalog No. A11472 M-CSFR, CSF1R inhibitorKi 20227 is an inhibitor of c-Fms tyrosine kinase (M-CSFR, CSF1R). Learn More -
Regorafenib Hydrochloride
Catalog No. A11546 VEGFR1/2/3/PDGFRβ/Kit/RET/Raf-1 inhibitorRegorafenib Hydrochloride is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively. Learn More -
CHMFL-ABL/KIT-155
Catalog No. A12421 ABL/c-KIT dual kinase inhibitorCHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155; compound 34) is a highly potent and orally active type II ABL/c-KIT dual kinase inhibitor. Learn More -
c-Kit-IN-2
Catalog No. A18440 c-KIT inhibitorc-Kit-IN-2 is a c-KIT inhibitor with an IC50 of 82 nM, shows superior antiproliferative activities against all the three GIST cell lines, GIST882, GIST430, and GIST48, with GI50s of 3, 1, and 2 nM, respectively. Learn More -
CHMFL-KIT-033
Catalog No. A18476 c-KIT T670I mutant inhibitorCHMFL-KIT-033 is a potent and selective inhibitor of c-KIT T670I mutant for gastrointestinal stromal tumors (GISTs), with an IC50 of 0.045 μM. Learn More -
Dasatinib Monohydrate
Catalog No. A16320 Dasatinib Monohydrate is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM, respectively. Learn More -
AC710 Mesylate
Catalog No. A16246 FLT3/KIT/PDGFRα/PDGFRβ inhibitorAC710 Mesylate is a potent, selective PDGFR-family kinases inhibitor with Kd values of 0.6 nM/1.0 nM/1.3 nM/1.0 nM for FLT3/KIT/PDGFRα/PDGFRβ respectively. Learn More -
AC710
Catalog No. A15933 FLT3/KIT/PDGFRα/PDGFRβ inhibitorAC710 is a potent, orally active, and selective platelet-derived growth factor receptor-family kinase inhibitor with potential anticancer activity. Learn More -
Pexidartinib (PLX3397)
Catalog No. A15520 CSF1/Kit/FLT3 inhibitorPexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity. Learn More -
Masitinib mesylate
Catalog No. A15152 KIT/PDGFR inhibitorMasitinib mesylate is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/800 nM, weak inhibition to ABL and c-Fms. Learn More -
Regorafenib (BAY 73-4506)
Catalog No. A10250 VEGFR inhibitorRegorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an orally bioavailable multikinase inhibitor targeting both the tumor and its vasculature. Learn More -
Pazopanib (GW-786034)
Catalog No. A11518 VEGFR inhibitorPazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β, and c-kit that blocks tumor growth and inhibits angiogenesis. Learn More -
Ki8751
Catalog No. A10502 VEGFR-2 inhibitorKi8751 is a cell-permeable quinolyloxyphenyl-urea compound that acts as a Flk-1 (VEGFR-2)-selective inhibitior in both cell-based and cell-free assays. Learn More -
Sunitinib Malate
Catalog No. A10880 RTK inhibitorSunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). Learn More -
Imatinib (Gleevec)
Catalog No. A10259 PDGFR inhibitorImatinib (Gleevec) is a number of tyrosine kinase enzymes specific inhibitor. Learn More -
Axitinib
Catalog No. A10103 VEGFR inhibitorAxitinib is a small molecule tyrosine kinase inhibitor,which inhibits multiple targets, including VEGFR-1, VEGFR-2, VEGFR-3, platelet derived growth factor receptor (PDGFR), and cKIT (CD117). Learn More -
XL184 free base (Cabozantinib)
Catalog No. A10996 VEGFR inhibitorXL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2. Learn More -
Masitinib ( AB1010)
Catalog No. A10558 c-Kit inhibitorMasitinib (AB1010) is a protein tyrosine kinase inhibitor. Learn More -
Imatinib Mesylate
Catalog No. A10468 Bcr-Abl inhibitorImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway. Learn More -
Dovitinib (TKI-258)
Catalog No. A11411 RTK inhibitorDovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively. Learn More -
Dasatinib (BMS-354825)
Catalog No. A10290 Abl-Src inhibitorDasatinib (BMS-354825) is an oral multi- BCR/ABL and Src family tyrosine kinase inhibitor. The main targets of dasatinib, are BCR/ABL, Src, c-Kit, ephrin receptors, and several other tyrosine kinases, but not erbB kinases such as EGFR or Her2. Learn More -
Tivozanib (AV-951)
Catalog No. A10101 VEGFR InhibitorTivozanib (AV-951) is an oral VEGF receptor tyrosine kinase inhibitor that is designed to inhibit all three VEGF receptors. Learn More -
Pazopanib HCl (GW786034)
Catalog No. A10699 VEGFR/PDGFR/FGFR inhibitorPazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β, and c-kit that blocks tumor growth and inhibits angiogenesis. Learn More -
AST 487
Catalog No. A15003 RET kinase inhibitorAST487 is a Ret kinase inhibitor/FLT3 inhibitor with IC50 of 0.88 uM for Ret. Learn More -
-
New
ISCK03
Catalog No. A17162 -
-
AZD3229 Tosylate
Catalog No. A16867 pan-KIT mutant inhibitorAZD3229 Tosylate is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors. Learn More -
Flumatinib
Catalog No. A16258 multi-kinase inhibitorFlumatinib is a multi-kinase inhibitor with IC50 Values of 1.2 nM, 307.6 nM and 2662 nM for c-Abl, PDGFRbeta and c-Kit respectively. Learn More -
MP470 (MP-470, Amuvatinib)
Catalog No. A10610 -
Vatalanib (PTK787) 2HCl
Catalog No. A10967 VEGFR inhibitorVatalanib (PTK787 or PTK/ZK) is a small molecule protein kinase inhibitor that inhibits angiogenesis that inhibits all known VEGF receptors, as well as platelet-derived growth factor receptor-beta and c-kit, but is most selective for VEGFR-2. CAS: 212141-51-0 (HCl) 212141-54-3 (Free base) Learn More -
PLX647
Catalog No. A15519 FMS/KIT inhibitorPLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respectively. Learn More -
Regorafenib monohydrate
Catalog No. A15218 Tyrosine kinase inhibitorRegorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively. Learn More -
N-Desethyl Sunitinib
Catalog No. A15182 VEGFR/PDGFRβ/KIT inhibitorN-desethyl sunitinib is a major and pharmacologically active metabolite of sunitinib, which is potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor (Ki values are 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT respectively). Learn More -
DCC-2618
Catalog No. A15062 C-Kit/PDGFR inhibitorDCC-2618 is a small molecule inhibitor of c-Kit and PDGFR with IC50s of 6 nM/30 nM/13 nM for c-Kit/PDGFRα/PDGFRβ respectively. Learn More -
AZD 2932
Catalog No. A14156 mutil-targeted protein tyrosine kinase inhibitorAZD2932 is a potent and mutil-targeted protein tyrosine kinase inhibitor with IC50 of 8 nM, 4 nM, 7 nM, and 9 nM for VEGFR-2, PDGFRβ, Flt-3, and c-Kit, respectively. Learn More -
Flumatinib mesylate
Catalog No. A13530 c-Abl/c-Kit/PDGRFβ inhibitorFlumatinib mesylate can reduce the expression of C-MYC, HIF-1 a and VEGF in U266 cell line in a time- and dose-dependent manners, so flumatinib mesylate may become a new drug for MM therapy. Learn More -
Toceranib (PHA 291639, SU 11654)
Catalog No. A11581 c-Kit, PDGFR, VEGFR inhibitorToceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ. Learn More -
Telatinib (BAY 57-9352)
Catalog No. A10903 VEGFR-2 inhibitorTelatinib (BAY 57-9352) is an orally available, small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β tyrosine kinases. Learn More -
Motesanib Diphosphate (AMG-706)
Catalog No. A10608 VEGFR inhibitorMotesanib, also known as AMG-706, is an orally administered multikinase inhibitor that selectively targets VEGF receptors, platelet-derived growth factor receptors, and Kit receptors. Learn More -
Dovitinib Dilactic acid (TKI258 Dilactic acid)
Catalog No. A10198 RTK inhibitorDovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor, which inhibits Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150 nM and 90 nM, respectively. Learn More -
OSI-930
Catalog No. A10679 c-Kit/VEGFR InhibitorOSI-930 is a potent inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck with IC50 of 80 nM, 9 nM, 8 nM, 15 nM, 41 nM and 22 nM, respectively. Learn More
40 Item(s)
per page
FILTER BY:
Shopping Options
- Actions
-
- Inhibitor (39)
- Antagonist (1)
- Target
-
- C-Raf (Raf-1) (1)
- CSF1R (4)
- FGFR (1)
- FGFR1 (2)
- FGFR3 (2)
- FLT3 (6)
- Kit (12)
- PDGFR (1)
- PDGFRα (5)
- PDGFRβ (8)
- RET (3)
- VEGFR1 (FLT1) (5)
- VEGFR2 (FLK1) (7)
- VEGFR3 (FLT4) (5)
Adooq Quality Guarantee
We promise all products perform as described.